Kamal Reader

Meta’s Connect conference held earlier this week had announcements ranging from the new $1,500 Quest Pro headset to the company’s partnership with Microsoft to bring productivity tools to VR. However, probably one of the most discussed updates was that Meta is finally bringing legs to its virtual avatars. Until now, Horizon Worlds users — which … Read more

Although real estate is the world’s biggest asset class, it is largely inaccessible to non-institutional investors. The large sums of capital often required for an individual to purchase property combined with the industry’s reliance on manual, antiquated processes pose substantial barriers to entry for individual investors looking to gain exposure to real estate. These challenges … Read more

Uganda’s controversial Computer Misuse (Amendment) Bill 2022, which rights groups say will likely be used to silence dissenting voices online, has come into force after the country’s president Yoweri Kaguta Museveni signed it into law yesterday. The country’s legislators had passed amendments to the 2011 Computer Misuse Act early September limiting writing or sharing of … Read more

Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. Before we get into this week’s show notes, some programming items: First up, use code “EQUITY” for a special listener discount for Disrupt tickets. We’re mere days away, and you should come hang out … Read more

Ori Mor Contributor Share on Twitter Ori Mor is chief business officer and co-founder of Wi-Charge. Creating a disruptive hardware components startup can be quite exciting. Few things can compare to the joy of physically interacting with your creation as you design and build it from scratch. But hardware startups are challenging. Think of it … Read more

Armed with $6.3 million in new pre-seed capital, Synonym Biotechnologies has begun the development phase for its first productized bio-manufacturing facilities for non-pharmaceutical applications. Edward Shenderovich and Joshua Lachter started the company in January 2022 to develop, finance and build commercial-scale bio-manufacturing facilities to provide synthetic biology producers of all size with flexible production capacity … Read more